376 related articles for article (PubMed ID: 37894746)
21. Role of histone deacetylases in bone development and skeletal disorders.
Wang JS; Yoon SH; Wein MN
Bone; 2021 Feb; 143():115606. PubMed ID: 32829038
[TBL] [Abstract][Full Text] [Related]
22. Fluorescent molecular probe-based activity and inhibition monitoring of histone deacetylases.
Roopa ; Priya B; Bhalla V; Kumar M; Kumar N
Chem Commun (Camb); 2021 Oct; 57(85):11153-11164. PubMed ID: 34613324
[TBL] [Abstract][Full Text] [Related]
23. Deacetylation of Transcription Factors in Carcinogenesis.
Halasa M; Adamczuk K; Adamczuk G; Afshan S; Stepulak A; Cybulski M; Wawruszak A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769241
[TBL] [Abstract][Full Text] [Related]
24. Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.
Hyndman KA
Semin Nephrol; 2020 Mar; 40(2):138-147. PubMed ID: 32303277
[TBL] [Abstract][Full Text] [Related]
25. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases.
Huang L
J Cell Physiol; 2006 Dec; 209(3):611-6. PubMed ID: 17001696
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylases and mechanisms of regulation of gene expression.
Chen HP; Zhao YT; Zhao TC
Crit Rev Oncog; 2015; 20(1-2):35-47. PubMed ID: 25746103
[TBL] [Abstract][Full Text] [Related]
27. Erasers of histone acetylation: the histone deacetylase enzymes.
Seto E; Yoshida M
Cold Spring Harb Perspect Biol; 2014 Apr; 6(4):a018713. PubMed ID: 24691964
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylases and cancer.
Barneda-Zahonero B; Parra M
Mol Oncol; 2012 Dec; 6(6):579-89. PubMed ID: 22963873
[TBL] [Abstract][Full Text] [Related]
29. The emerging roles of HDACs and their therapeutic implications in cancer.
Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X
Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787
[TBL] [Abstract][Full Text] [Related]
30. The roles of histone deacetylases in kidney development and disease.
Liu H
Clin Exp Nephrol; 2021 Mar; 25(3):215-223. PubMed ID: 33398599
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of histone deacetylases.
Huang Y; Shaw PG; Davidson NE
Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
[TBL] [Abstract][Full Text] [Related]
32. Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention.
Ganai SA
Curr Drug Targets; 2018; 19(6):593-601. PubMed ID: 27231104
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylases in kidney development: implications for disease and therapy.
Chen S; El-Dahr SS
Pediatr Nephrol; 2013 May; 28(5):689-98. PubMed ID: 22722820
[TBL] [Abstract][Full Text] [Related]
34. Class II histone deacetylases: versatile regulators.
Verdin E; Dequiedt F; Kasler HG
Trends Genet; 2003 May; 19(5):286-93. PubMed ID: 12711221
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylases: target enzymes for cancer therapy.
Mottet D; Castronovo V
Clin Exp Metastasis; 2008; 25(2):183-9. PubMed ID: 18058245
[TBL] [Abstract][Full Text] [Related]
36. Role of Histone Deacetylases in T-Cell Development and Function.
Pieniawska M; Iżykowska K
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887172
[TBL] [Abstract][Full Text] [Related]
37. The structure and function of histone deacetylases: the target for anti-cancer therapy.
Zhang Y; Fang H; Jiao J; Xu W
Curr Med Chem; 2008; 15(27):2840-9. PubMed ID: 18991639
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylases: unique players in shaping the epigenetic histone code.
Thiagalingam S; Cheng KH; Lee HJ; Mineva N; Thiagalingam A; Ponte JF
Ann N Y Acad Sci; 2003 Mar; 983():84-100. PubMed ID: 12724214
[TBL] [Abstract][Full Text] [Related]
39. Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.
Korfei M; Mahavadi P; Guenther A
Cells; 2022 May; 11(10):. PubMed ID: 35626663
[TBL] [Abstract][Full Text] [Related]
40. Histone Deacetylase Modifications by Probiotics in Colorectal Cancer.
Salek Farrokhi A; Mohammadlou M; Abdollahi M; Eslami M; Yousefi B
J Gastrointest Cancer; 2020 Sep; 51(3):754-764. PubMed ID: 31808058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
